• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

GSK3368715 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5753254

GSK3368715 is an orally active, reversible, and S-adenosyl-L-methionine (SAM) uncompetitive type I protein arginine methyltransferases (PRMTs) inhibitor (IC50s: 3.1nM (PRMT1), 48nM (PRMT3), 1148nM (PRMT4), 5.7nM (PRMT6), 1.7nM (PRMT8)). It has strong… More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
GSK3368715, Inhibitor
Full Product Name
GSK3368715
Product Gene Name
Product Synonym Names
EPZ019997
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
366.54
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C20H38N4O2
SMILES
CNCCN(CC1=CNN=C1C2CCC(COCC)(COCC)CC2)C
CAS Number
1629013-22-4
Target & IC50
PRMT1: ic50 3.1nM
PRMT3: ic50 48nM
PRMT4: ic50 1148nM
PRMT6: ic50 5.7nM
PRMT8: ic50 1.7nM
In Vitro
GSK3368715 significantly effects on the growth of BxPC3 xenografts at all doses tested, reducing tumor growth by 78% and 97% in the 150- and 300-mg/kg dose groups, respectively.

Product References and Citations for GSK3368715, inhibitor

Fedoriw A, et al. Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss. Cancer Cell. 2019 Jul 8;36(1):100-114.e25.
Fedoriw A, et al. Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss. Cancer Cell. 2019 Jul 8;36(1):100-114.e25.

Other Notes

Small volumes of GSK3368715, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for GSK3368715 purchase

MBS5753254 is an inhibitor targeting GSK3368715.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000